Product
Eureka
For R&D, Eureka makes reading and utilizing patents & technical documents easy.
Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
9138 results about "Flavones" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Flavones (flavus = yellow), are a class of flavonoids based on the backbone of 2-phenylchromen-4-one (2-phenyl-1-benzopyran-4-one) (right image). Flavones are common in the food supply, mainly from spices, and red–purple fruits and vegetables. Common flavones include apigenin (4',5,7-trihydroxyflavone), luteolin (3',4',5,7-tetrahydroxyflavone), tangeritin (4',5,6,7,8-pentamethoxyflavone), chrysin (5,7-dihydroxyflavone), and 6-hydroxyflavone.
Process for increasing the flavonoid content of a plant and plants obtainable thereby
InactiveUS7208659B2Improve survivabilityIncrease the content of flavonoidsTransferasesOther foreign material introduction processesHorticultureFood products
Owner:CONOPCO INC D B A UNILEVER
Method for supplementing the diet
InactiveUS6579544B1Increased susceptibilityPrevent diseaseHeavy metal active ingredientsBiocideDietary supplementAlpha-Lipoic Acid
A dietary supplement blend composition is disclosed, the basic formulation of the composition containing vitamins, minerals, and carotenoids. The composition can also contain bioflavonoids, cartilage protectors such as glucosamine or chondroitin, alpha-lipoic acid, coenzyme Q10, and a source of omega-3 fatty acids such as flax seed oil. The composition is beneficial for improving health and preventing disease, particularly for degenerative conditions. A method for supplementing the diet is also disclosed, wherein the quantity of daily rations of the dietary supplement blend composition is determined based on the person's age, body weight, and quality of diet.
Owner:NUTRIEX
Metabolic capacity enhancing compositions and methods for use in a mammal
InactiveUS20060024385A1Increase vitalityImproved and increased energy processing of given caloric foods)BiocideOrganic active ingredientsLipid formationMammal
Metabolic energy capacity enhancing compositions and methods for reducing oxidative stress and improving vitality in a mammal are disclosed. A composition for increasing metabolic energy capacity may be in a palatable liquid formulation or a solid dosage form and typically includes an anti-oxidant containing phytonectar and an energy catalyst. An anti-oxidant may include a polyphenol, anthrocyanin, bioflavonoid, proanthocyanidin, and a xanthone. An energy catalyst may include a mineral, vitamin, co-vitamin, carbohydrate and a lipid. In a presently preferred embodiment a composition includes phytonectar extracts from grape, aloe vera, apple, morinda citrifolia, scullcap, blueberry, prune, cranberry, elderberry, bilberry, and gentain and a mineral blend containing calcium, magnesium, manganese, zinc, chromium, selenium, iron, copper, molybdenum, vanadium, potassium, iodine, and cobalt. A method for increasing metabolic energy capacity in a mammal may include consuming a chemical component having the ability to undergo oxidation, producing free radicals and administering a composition having an anti-oxidant containing phytonectar and an energy catalyst.
Owner:PEDERSEN MARK A
Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
Compositions and methods for the prevention and treatment of neoplastic diseases are described. Individuals at a high risk of developing or having neoplasia undergoing conventional therapies may be treated with an effective dose of triterpene derivatives in limonoids, polyphenolic flavonoid compounds, tocotrienols or a combination of these agents.
Owner:INTERHEALTH NUTRACEUTICALS
Nutraceutical composition and method of use for treatment / prevention of cancer
InactiveUS20070248693A1Function increaseAbility to createBiocideAlgae medical ingredients1,4-BenzoquinonePantothenic acid
The invention describes a pharmaceutical composition and method for treating cancer comprised of A) 2,3-dimethoxy-5-methyl-1,4-benzoquinone and / or B) at least one of wild yam root, teasel root, balm of gilead bud, bakuchi seed, dichroa root, kochia seed, kanta kari, bushy knotweed rhizome, arjun, babul chall bark, opopanax and bhumy amalaki; optionally one or more of frankincense, garcinia fruit, vitex, dragons blood, mace, sage and red sandalwood with at least c) one compound capable of maximizing oxidative mitochondrial function preferably riboflavin or vitamin B2 derivatives, FAD, FMN, 5-amino-6-(5′-phosphoribitylamino)uracil, 6,7-Dimethyl-8-(1-D-ribityl)lumazine, ribitol, 5,6-dimethylbenzimidazole, tetrahydrobiopterin, vitamin B1, lipoic acid, biotin, vitamin B6, vitamin B12, folate, niacin, vitamin C and pantothenate and / or d) at least one lactic acid dehydrogenase inhibitor (preferably 2′,3,4′5,7-pentahydroxyflavone) and optionally f) an alkalizing agent (aloe vera, chlorella, wheat grass, sodium or potassium bicarbonate, potassium) g) an antiproliferative herb (speranskia or goldenseal) and h) a pharmaceutically acceptable carrier.
Owner:MAZZIO ELIZABETH +1
Methods For Treating Wounds
InactiveUS20030125264A1Increasing cell proliferationPromote cell growthBiocideCarbohydrate active ingredientsFibroblastPharmaceutical drug
Pharmaceutical compositions, and methods of using the same, are provided utilizing effective amounts of one or more flavones, flavonols, flavanones, isoflavanones and isoflavones to increase cell proliferation in various tissues and cell lines. As examples, the composition and methods of the present invention can be used to increase proliferation of fibroblast cells and, more particularly, in the treatment of wounds as well as strengthening of the skin.
Owner:KIMBERLY-CLARK WORLDWIDE INC
Flavonoide esters and their use notably in cosmetics
The invention relates to a flavonoid ester. This flavonoid ester results from the reaction product of at least one flavonoid selected from the group consisting of a flavonoid with a ketone group in the 4-position, a salt, ester or ether of such a flavonoid, and a C-heteroside and / or O-heteroside derivative of such a flavonoid, with the proviso that this flavonoid contains at least one free alcohol group, with an organic monoacid having from 3 to 30 carbon atoms. These flavonoid esters constitute useful active principles for the manufacture of cosmetic, dermopharmaceutical, pharmaceutical, dietetic or agri-foodstuff compositions.
Owner:BASF BEAUTY CARE SOLUTIONS FRANCE SAS
Oral care compositions containing flavonoids and flavans
InactiveUS20060140881A1Improve bioavailabilityCosmetic preparationsAntipyreticFlavonesBioavailability
Oral care compositions containing: a free-B-ring flavonoid and a flavan; as well as at least one bioavailability-enhancing agent are provided. Methods of using the oral compositions are also provided.
Owner:COLGATE PALMOLIVE CO
Composition and method for reducing the risk or progression of cardiovascular, glaucoma, tardive dyskinesia and other diseases
InactiveUS20040087479A1Reduce riskShorten the progressBiocideOrganic active ingredientsBeta-CaroteneAdditive ingredient
Elevated levels of homocysteine have been implicated as an important risk factor for cardiovascular and other diseases. A composition for decreasing levels of plasma homocysteine and a method for administering the composition are provided, the composition containing dextromethorphan (DM), folic acid and vitamins B6 and B12. The composition provides a synergistic therapeutic effect so that lower amounts of the above ingredients may be employed to minimize any undesirable side effects caused by the use of high levels of a component such as DM. Preferred compositions for cardiovascular diseases further include lecithin, vitamin E, betacarotene, procyanidins / flavonoids, trimethylglycine, garlic oil and minerals. Other compositions for treating glaucoma include bilberry, bioflavonoids and beta-carotene and for treating tardive dyskinesia include an antioxidant such a grape seed extract and pine bark extract, lecithin and oligomeric proanthocyanidins. The compositions may be administered using any suitable means such as orally or intravenous.
Owner:SOSNOWSKI ROBERT E +1
Nitric oxide donating derivatives for the treatment of cardiovascular disorders
InactiveUS20050080024A1Increases extentIncreases pathological severityBiocideSugar derivativesVascular diseaseEndothelial dysfunction
Compounds comprising nitric oxide derivatives of stilbenes, polyphenols and flavonoids and methods of their use are provided for treating patients suffering from any of hypercholesterolemia, vascular oxidative stress and endothelial dysfunction.
Owner:RESVERLOGIX
Method for protecting humans against superficial vasodilator flush syndrome,
InactiveUS20090148543A1Significant timeImprove the level ofAntibacterial agentsBiocideSulfate proteoglycanS-Adenosyl-l-methionine
Methods for protection of a human from SVFS comprise the administration of a flavonoid compound of the basic structures 2-phenyl-4H-1-benzopyran or 2-phenyl-4-keto-1-benzopyran or glycosides thereof, alone or, optionally, together with one or more of an olive kernel extract, a non-bovine sulfated proteoglycan, bitter willow extract, a D-hexosamine sulfate, S-adenosylmethionine, folic acid, vitamin B12 and a serotonin inhibitor. Such treatment prevents, reduces or eliminates SVFS in patients receiving as much as 300-3000 mg / day of niacin therapeutically, whether administered prior to, or along with, an anti-SVFS composition.
Owner:THETA BIOMEDICAL CONSULTING & DEVMENT
Electronic cigarette liquid rich in plant flavone
ActiveCN104068467AMeeting smoking needsWill not affect healthTobacco treatmentNicotiana tabacumPropolis
The invention discloses an electronic cigarette liquid rich in plant flavone. The electronic cigarette liquid comprises the following raw materials in percentage by mass: 50-70% of propylene glycol, 5-10% of glycerinum, 5-15% of deionized water, 5-15% of natural flavone extract, 4-8% of tobacco extract, 2-6% of tobacco essence and 2-6% of thickener, wherein the natural flavone extract is the extract obtained by distilling by vapour or extracting a plant mixture by ethyl alcohol, and the total flavonoid content is 20-50% by total flavonoid content; the plant mixture is composed of chuzhou chrysanthemum, iris tectorum roots, propolis, orange peel, grape, peanut coat, lily, radix puerariae, scutellaria baicalensis, roxburgh rose and green tea. The electronic cigarette liquid disclosed by the invention is capable of meeting the smoking needs of smokers; meanwhile, the rich plant flavone has the effects of resisting oxidization, preventing aging, and adjusting immunity, and also has a healthcare effect on heart and cerebral vessels to a certain extent.
Owner:CHINA TOBACCO ANHUI IND CO LTD
Isolation of polyphenolic compounds from fruits or vegetables utilizing sub-critical water extraction
InactiveUS7208181B1Effective applicationEffective isolationBiocideAdhesive dressingsPhytochemicalDietary supplement
Anthocyanins, other flavonoids and related polyphenolic compounds are extracted from fruits or highly pigmented garden vegetables and their by-products using subcritical water with or without a secondary cosolvent. This method has the advantages of being relatively inexpensive, minimizes or totally avoids the use of objectionable solvents, and provides a facile means for supplying an ample source of concentrated phytochemicals for use in food formulation, dietary supplements and phyto-pharmaceutical applications.
Owner:US SEC AGRI
Method for extracting and separating 1-deoxynojirimycin with high purity from natural products
InactiveCN101654428AConducive to in-depth development and utilizationLow costOrganic chemistryAnimal feeding stuffSolventIon-exchange resin
The invention relates to the field of the traditional Chinese medicine, in particular to a method for extracting and separating 1-deoxynojirimycin (DNJ) with the purity higher than 98% from natural products comprising mulberry leaves, mulberry twigs, white mulberry root-bark, mulberry fruit and silkworm litter and also preparing a 1-deoxynojirimycin crude product (with the purity more than 35%), protein feeds, crude flavone and refined polysaccharide (with the purity more than 90%). The method mainly comprises the following steps: extracting a raw material of dry powder by a hydrophilic solvent, soaking by anion exchange resin after acidizing and concentrating extracting liquid, carrying out chromatography by a cation exchange column after concentrating effluent liquid and water washing liquid, extracting by an organic solvent, recrystallizing, carrying out chromatography by a gel column and purifying. The content of the 1-deoxynojirimycin in the obtained product is not less than 98%,and the concrete execution already enters intermediate test.
Owner:CHENGDU GOLD DOCTOR TECH HEALTH IND +2
Medicinal mixture possessing alpha glycocidase inhibiting activity and its use
ActiveCN1559539AThe mechanism of action is clearDefinite curative effectOrganic active ingredientsAnthropod material medical ingredientsMedicineSmall intestine
A medicine with high activity to suppress alpha-glucosidase for treating diabetes, and hyperlipemia, and delaying sanility contains the common alkaloid extracted from mulberry plants and the flavone extract.
Owner:LONGSHUNRONG PHARMA FACTORY TIANJIN ZHONGXIN PHARMA GRP
Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
ActiveUS20060003947A1High riskImprove bioavailabilityBiocideHydrocarbon active ingredientsPlant sterolBULK ACTIVE INGREDIENT
The present invention is directed to soft gel compositions, methods of delivery and packaged nutraceuticals of the soft gel compositions that include at least one polymethoxylated flavone and, optionally, at least one tocotrienol. Optional active ingredients include a phytosterol, DHA, EPA, coenzyme Q-10 or an analog thereof and mixtures thereof.
Owner:SOFT GEL TECHNOLGIES
Method for extracting suaeda salsa flavone and measuring content of flavones in suaeda salsa
InactiveCN103027962AImprove production rateIncrease profitAntipyreticComponent separationConcentration gradientSolvent
Owner:YANCHENG INST OF IND TECH
Methods of administering anti-inflammatory cyclooxygenase-2 selective inhibitors
InactiveUS20070003646A1Good choiceBroader spectrum of therapeutic benefitBiocideAntipyreticSide effectCyclooxygenase
Owner:LIPOPROTEIN TECH
Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
Compositions and methods for the prevention and treatment of neoplastic diseases and hypercholesterolemia are described. Individuals at a high risk of developing or having neoplasia or hypercholesterolemia undergoing conventional therapies may be treated with an effective dose of triterpene derivatives in citrus limonoids, polyphenolic flavonoid citrus compounds, tocotrienols or a combination of these agents.
Owner:INTERHEALTH NUTRACEUTICALS
Method for preparing stevia whole stevioside and stevia whole flavone at the same time
ActiveCN101062077AImprove mildew resistanceConducive to food preservationSugar derivativesMetabolism disorderLuteolinGlucoside
The invention discloses a preparing method of total sweet chrysanthemum glycosides and total chromocor in sweet leaf chrysanthemum, which is characterized by the following: comprising sweet chrysanthemum glycosides, stevi primary glycosides, labroid glycosides A, B, C, D, E, F, duacl glycosides A and so on in total sweet chrysanthemum glycosides; comprising cyanidenon, meletin, cyanidenon-7-0-beta-D glycosides, celery element-7-0-beta-D-glycosides, quercetin, meletin-3-0-beta-D-arabinoside, meletin-3-0-[4-0-trans-coffe acyl-alpha-L-isodulcitol-(1-6)-beta-D-arabinoside] and so on; choosing one or several methods from solvent extraction, solvent extraction process, macroreticular absorption resin method, column chromatography, supercritical fluid chromatography, liquid-liquid counter-current partition chromatography and so on; extracting the total chromocor; setting content of sweet chrysanthemum glycosides element in total sweet chrysanthemum glycosides at 5-100%; counting 5-100% of all sweet chrysanthemum glycosides content with sweet chrysanthemum glycosides and labroid glycosides; counting 5-100% of chromocor element in sweet leaf chrysanthemum total chromocor; counting 5-100% of all total chromocor content with cyanidenon-7-0-beta-D glycosides, quercetin and meletin-3-0-[4-0-trans-coffe acyl-alpha-L-isodulcitol-(1-6)-beta-D-arabinoside].
Owner:石任兵 +1
Method of extracting and separating several components from mangsteen
InactiveCN1375499AImprove immunityGood sweetenerOrganic compounds purification/separation/stabilisationSugar derivativesChemistryPolyamide
The method for extracting and separating several components from Grosvenor's momordica fruit includes the following steps: washing Grosvenor's momordica fruit with water, using alkaline water to treat broken Grosvenor's momordica fruit to obtain extract, then using aliphatic alcohol to make treatment to obtain precipitate and dissolved liquor, making the precipitate pass through anion-exchange resin column and undergo the processes of aliphatic alcohol treatment and purification to obtain the Grosvenor's momordica fruit polysaccharide, and making the dissolved liquor pass through the polyamide resin column and macroporous resin column and undergo the process of aliphatic alcohol treatment to obtain Grosvenor's momordica fruit glycoside, and making the component adsorbed by polyamide resincolumn undergo the processes of washing with basic aliphatic alcohol.
Owner:何伟平
Isoflavone derivatives
InactiveUS20060251592A1Improve bioavailabilityEasily hydrolyzedCosmetic preparationsBiocideSolubilityPhosphate
Owner:VYREXIP HLDG
8-(C-beta-D-glucopyranosyl)-7, 3', 4'-trihydroxyflavone, process of isolation thereof, pharmaceutical composition and method for the treatment of diabetes
Owner:COUNCIL OF SCI & IND RES
Bamboo leaf antioxide and use thereof
InactiveCN1528197AWide variety of sourcesMild flavorAntibacterial agentsFood ingredient as antioxidantNitriteWater soluble
Owner:ZHEJIANG UNIV HANGZHOU LEAF BIO TECH
Composite extracting technique for coproduction of mulberry tea flavone, polysaccharide and alkaloid
InactiveCN101412703AHigh economic valueIncrease profitAlkaloids chemistryAlkaloidsAdditive ingredientCogeneration
The invention relates to a complex extraction process for mulberry leaf flavonoid, polysaccharide and alkaloid through cogeneration, which is characterized by having the following extraction steps: raw material processing, extraction, and separation. The complex extraction process adopting a complex extraction method for the mulberry leaf flavonoid, the polysaccharide and the alkaloid obtained through the cogeneration has the advantages of mild condition, low energy consumption, small environment pollution; macroporous absorbent resin and chloroform used in the complex extraction process can be reused through regeneration; the economic value of the obtained effective ingredients is very high; the mulberry leaf resource is greatly saved; a new utilization approach of the agricultural product mulberry leaf is opened up; and the medicinal utilization value and the economic added value of the mulberry leaf are improved.
Owner:JIANGSU UNIV OF SCI & TECH
Citrus aurantium total flavone extract and the preparing method thereof
The invention discloses a total chromocor extract from traditional medicine citrus fruit and preparing method, which is characterized by the following: comprising pomelo ped glycosides, new orange peel glycosides, orange peel glycosides, pomelo ped rutin, derivant and so on; choosing one or several methods from solvent extraction, solvent extraction process, macroreticular absorption resin method, lead salt precipitation method, column chromatography, supercritical fluid chromatography, liquid-liquid counter-current partition chromatography and so on; producing extract; setting percentage content of various chromocor element at 5-100%(w / w) in the extract; counting 5-100%(w / w) of pomelo ped glycosides, new orange peel glycosides, orange peel glycosides in total chromocor content.
Owner:石任兵 +1
Compositions of flavonoids and flavonoid-containing extracts and the treatment of diseases
In this invention, we describe a group of flavonoids and flavonoid-containing extracts that have pharmaceutical properties which are useful in the medicinal therapy of fibrotic diseases for the treatment or reparation and prevention of fibrotic lesional tissues. Representative flavonoids and flavonoid-containing extracts have the active compositions of the below formula. Those compositions can be extracted and purified from the botanicals, including Scutellaria baicalensis Georgi, Scutellaria scordifolia Fisch,Oroxylum indicum(L.) Vent, Plantago major L. The compositions of the invention are novel as an anti-fibrotic drugs, as agents for treating fibrosis.
Owner:SHANGHAI COMMAN PHARMA
Compositions and method for treatment of steroid/nuclear receptor-mediated diseases
Compositions and method for treatment of steroid / nuclear receptor-mediated diseases. The present invention relates to non-aqueous extracts of Astragalus Membranaceus (HQ) and to compositions thereof. Also provided is a method for the treatment of PPAR-mediated physiological conditions comprising administering to a subject an effective amount of at least one of the above mentioned extracts and also a method for augmenting or synergising the activity of ligands of steroid / nuclear receptors comprising administering to a subject an effective amount of at least one of: an extract of Astragalus Membranaceus (HQ) or a flavonoid compound; in the presence of at least one ligand of steroid / nuclear receptors.
Owner:NAT UNIV OF SINGAPORE
Anti-inflammatory compositions for treating multiple sclerosis
Compositions with synergistic anti-inflammatory effects in inflammatory diseases resulting from activation and consequent degranulation of mast cells and followed by secretion of inflammatory biochemicals from the activated mast cells, the compositions containg one or more of a flavone or flavonoid glycoside a heavily sulfated, non-bovine proteoglycan, an unrefined olive kernel extract that increases absorption of these compositions in various routes of administration, a hexosamine sulfate such as D-glucosamine sulfate, S-adenosylmethionine, a histamine-1 receptor antagonist, a histamine-3 receptor agonist, an antagonist of the actions of CRH, a long-chain unsaturated fatty acid, a phospholipid, Krill oil, a polyamine, glutiramer acetate and interferon. Certain of the present compositions are useful in protecting against the neuropathological components of multiple sclerosis and similar inflammatory neurological diseases.
Owner:THETA BIOMEDICAL CONSULTING & DEVMENT
Selenium-enriched suaeda salsa nutritional health-care fine dried noodles and production technology thereof
PendingCN106578918AReddish colorEasy to shapeYeast food ingredientsFood ingredient as taste affecting agentAdditive ingredientFried noodles
Owner:QINGDAO JIARUI BIOLOGICAL TECH
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com